Skip to Content

The Top- and Bottom-Performing U.S. Equity Funds From the First Half

I look at the highlights and lowlights in equityland.

We're halfway into 2015, so let's take a look at the winners and losers among U.S. equity funds. I looked at the top and bottom performers in the Morningstar 500 by total return and ranking relative to their Morningstar Category. It's a useful exercise because everyone wants to know why their fund is having extreme performance, and that information can help you to understand how other funds in your portfolio performed.

Obligatory caveat: This isn't a buy list. That's what our Morningstar Medalists list is for. We have hundreds of medalists, and you can winnow the list based on your own criteria.

Top Five Performers T. Rowe Price Health Sciences PRHSX Total Return: 20% Category Rank: Top 13% Yes, it sounds like a broken record, but health care did well, and smaller biotech and pharma names did even better. Mergers keep driving the market higher, and this fund's emphasis on the small/mid-cap end of health care has been a boon. This fund's long rally has assets up to $15.5 billion, and the fund recently closed to new investors.

Century Small Cap Select

CSMVX

Total Return: 14% Category Rank: Top 3%

This fund really needed the rebound. It lagged peers badly in 2013 and 2014. The fund has dialed up health-care exposure, and names such as

Vanguard Health Care

VGHCX

Total Return: 14% Category Rank: Top 61%

Mega-cap health-care stocks haven't been too shabby, either. Even dull names like UnitedHealth Group and Cigna are enjoying big rallies this year. The Supreme Court's ruling upholding the Affordable Care Act didn't hurt.

Fidelity Select Health Care FSPHX

Total Return: 13% Category Rank: Top 68%

See my comments above. For this fund,

Scotia Dynamic U.S. Growth DWUGX

Total Return: 13% Category Rank: Top 1%

This superaggressive fund focuses on companies with the highest earnings-growth rates. As you can see, it's pretty when that clicks, but taking on a lot of price risk means it has a severe downside. Among the top performers in the portfolio are

Top Relative Performers Scotia Dynamic U.S. Growth is also top 1%. Here are some more.

Dreyfus Opportunistic Small Cap DSCVX Total Return: 10% Category Rank: Top 1% David Daglio's bold fund is usually at the top or bottom of fund rankings. This year it is up 10% and in the top 1% of its peer group. He concentrates the portfolio on four sectors: technology, industrials, consumer cyclicals, and financials. His strategy is an unusual blend of value and growth names, and this year he's hitting on a lot of winners from both sides such as SVB Financial SIVB and Infoblox BLOX.

Thornburg Value TVAFX

Total Return: 7% Category Rank: Top 1%

This fund suffered an awful stretch from 2010 through 2012 but has since rebounded nicely. Giving an overweighting to health care has worked well, but so have some well-placed consumer bets such as

CGM Focus CGMFX

Total Return: 6% Category Rank: Top 1%

Ken Heebner's fund needed a rally, and it's up 6% to land in the top 1% of its peer group for the year to date. It was in a brutal slump in part because of a 23% short against Treasuries. However, that's helped this year, as have long positions in

Sequoia SEQUX

Total Return: 11% Category Rank: Top 2%

This closed fund has 26% of assets in Valeant Pharmaceuticals International. Valeant is up 67% for the year to date, and as a result, the fund is up 11%. That's pretty much the whole story. The fund actually has quite a few names that are in the red, including

Fidelity Small Cap Stock FSLCX

Total Return: 9% Category Rank: Top 2%

Lionel Harris' focus on quality stocks has led the fund to some winners from a wide array of industries. He keeps individual stock bets small, but he does have some sector biases. In particular, he's been leaning toward technology and financials stocks.

Worst Performers

Franklin Utilities FKUTX

Total Return: Negative 10% Category Rank: Top 78%

A surge in the U.S. economy has increased the likelihood of the Fed raising rates this year, and that in turn has led interest rates to rise. Utilities are quite sensitive to interest rates because people own them for their yield. Franklin Utilities is lagging most utilities funds for the year to date because it focuses on U.S. electric and natural gas utilities. These stocks have higher yields but greater interest-rate sensitivity.

Janus Contrarian JSVAX

Total Return: Negative 7% Category Rank: Top 99%

How the heck did a large-blend fund that has an overweighting in health care end up with a 7% year-to-date loss? Dig into the portfolio and you'll see some really beaten-down value stocks. When investors decide a battered stock is a value trap instead of a value, it can get ugly. Of course, all these holdings could rally, but for now it's not pretty. Number-two holding

Vanguard REIT Index

VGSLX

Total Return: Negative 6% Category Rank: Top 71%

and

Fidelity Real Estate Investment FRESX

Total Return: Negative 5% Category Rank: Top 34%

We are back to our interest-rate sensitivity theme. REITs are yield plays like utilities and thus are vulnerable to an interest-rate spike. The Fidelity fund is actually doing a bit better than most REIT funds.

AMG Yacktman Focused YAFFX

Total Return: Negative 5% Category Rank: Top 99%

Among large caps, even some names considered blue chips have been singed. This fund is down 5% and in the bottom 2% of its peer group. Only two of this fund's top 10 are in the black. Among the hard-hit are

Lagging Relative Performers AMG Yacktman Focused and Janus Contrarian were two of the three with next-to-last percentile performance.

FPA Perennial FPPFX

Total Return: Negative 5% Category Rank: Top 99%

This fund is getting a new name, manager, and strategy. On Sept. 1, Greg Nathan takes over what will be FPA U.S. Value. In the meantime, transportation stocks like

AMG Yacktman YACKX

Total Return: Negative 5% Category Rank: Top 98%

The story is the same as that of AMG Yacktman Focused, only with smaller position sizes.

FPA Capital FPPTX

Total Return: Negative 4% Category Rank: Top 98%

Energy stocks plus for-profit education stocks like DeVry DV and

More in Funds

About the Author

Russel Kinnel

Director
More from Author

Russel Kinnel is director of ratings, manager research, for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He heads the North American Medalist Rating Committee, which vets the Morningstar Medalist Rating™ for funds. He is the editor of Morningstar FundInvestor, a monthly newsletter, and has published a number of prominent studies of the fund industry covering subjects such as manager investment, expenses, and investor returns.

Since joining Morningstar in 1994, Kinnel has analyzed virtually every type of fund and has covered the most prominent fund families, including Fidelity, T. Rowe Price, and Vanguard. He has led studies on the predictive power of fund data and helped develop the Morningstar Rating for funds and the Morningstar Style Box methodology. He was co-author of the company's first book, Morningstar Guide to Mutual Funds: 5-Star Strategies for Success (Wiley, 2003), and was author of the book Fund Spy: Morningstar's Inside Secrets to Selecting Mutual Funds That Outperform, published in 2009.

Kinnel holds a bachelor's degree in economics and journalism from the University of Wisconsin.

Sponsor Center